Literature DB >> 31780139

Effect of reversal of deep neuromuscular block with sugammadex or moderate block by neostigmine on shoulder pain in elderly patients undergoing robotic prostatectomy.

Wendell H Williams1, Juan P Cata2, Javier D Lasala2, Neema Navai3, Lei Feng4, Vijaya Gottumukkala2.   

Abstract

BACKGROUND: For some laparoscopic procedures, deep neuromuscular block has been shown to facilitate lower insufflation pressures and lower patient pain scores, and enhance postoperative recovery. We investigated the impact of deep neuromuscular block and its reversal on postoperative shoulder pain and outcomes after robotic prostate surgery.
METHODS: Elderly men undergoing robotic prostatectomy were randomised to deep neuromuscular block (target post-tetanic twitch of 1-2 at the facial nerve) with sugammadex reversal or moderate neuromuscular block (target 1-2 train-of-four ratio) with neostigmine reversal. The primary endpoint was postoperative shoulder pain. The secondary endpoints included intraoperative insufflation pressure, surgical rating score, incidence of residual neuromuscular block, and postoperative recovery.
RESULTS: A total of 50 subjects for each treatment arm were included in the analysis. The degree of neuromuscular block had no effect on the incidence of shoulder pain (deep block group 12% vs moderate block group 10%; P=1.0) or average insufflation pressure (median [inter-quartile range]) (13.3 [12.5-13.6] mm Hg vs 13.3 [11.7-14] mm Hg, P=0.86). After surgery, the deep block group had a higher normalised train-of-four ratio (0.98 [0.79-1.11] vs 0.85 [0.74-1.00]; P=0.008). The presence of postoperative shoulder pain was associated with higher BMI (31.8 [28-33.9] kg m-2vs 28 [24.8-31.1] kg m-2; P=0.036) and longer insufflation time (186 [156-257] min vs 154 [126-198] min; P=0.028).
CONCLUSIONS: The use of deep neuromuscular block during surgery does not decrease postoperative shoulder pain or enhance recovery after robotic prostatectomy. CLINICAL TRIAL REGISTRATION: NCT03210376.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  complications; neostigmine; neuromuscular blocking agent; prostatectomy; residual neuromuscular block; sugammadex

Mesh:

Substances:

Year:  2019        PMID: 31780139     DOI: 10.1016/j.bja.2019.09.043

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  5 in total

1.  Comparison of the effects of deep and moderate neuromuscular block on respiratory system compliance and surgical space conditions during robot-assisted laparoscopic radical prostatectomy: a randomized clinical study.

Authors:  Shao-Jun Zhu; Xiao-Lin Zhang; Qing Xie; Yan-Feng Zhou; Kui-Rong Wang
Journal:  J Zhejiang Univ Sci B       Date:  2020 Aug.       Impact factor: 3.066

2.  Sugammadex in awakening from general anesthesia: systematic review and meta-analysis.

Authors:  Adriano Anzai; Armelin Utino; Giuliano Tosello; Haroldo Katayama; Ighor Alexander Zamuner Spir; Luca Schiliró Tristão; Mary Martins Nery; Mauricio Anhesini; Osvaldo Silvestrini Tiezzi; Patricia Rodrigues Naufal Spir; Pericles Otani; Wanderley Marques Bernado
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-09       Impact factor: 1.712

3.  To drain or not to drain: the association between residual intraperitoneal gas and post-laparoscopic shoulder pain for laparoscopic cholecystectomy.

Authors:  Shun-Chin Yang; Kuang-Yi Chang; Ling-Fang Wei; Yi-Ming Shyr; Chiu-Ming Ho
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

4.  Increased body mass index is associated with operative difficulty during robot-assisted radical prostatectomy.

Authors:  Daniel D Shapiro; John W Davis; Wendell H Williams; Brian F Chapin; John F Ward; Curtis A Pettaway; Justin R Gregg
Journal:  BJUI Compass       Date:  2021-09-27

5.  Deep neuromuscular block does not improve surgical conditions in patients receiving sevoflurane anaesthesia for laparoscopic renal surgery.

Authors:  G H Maarten Honing; Christian H Martini; Erik Olofsen; Rob F M Bevers; Volkert A L Huurman; Ian P J Alwayn; Monique van Velzen; Marieke Niesters; Leon P H J Aarts; Albert Dahan; Martijn Boon
Journal:  Br J Anaesth       Date:  2020-10-20       Impact factor: 9.166

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.